Equity Holdings of Nippon India Pharma Fund
Here is the most recent list of
equity holdings in the Nippon India Pharma Fund's portfolio
as of 28 Feb 2025 . The fund's AUM is 6,891.31 crores, of which equity holdings constitute 98.88%.
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 13.68% |
| DIVI'S LABORATORIES LTD. | 9.32% |
| LUPIN LTD. | 7.73% |
| CIPLA LTD. | 5.90% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.14% |
| ABBOTT INDIA LTD. | 3.82% |
| Vijaya Diagnostic Centre Ltd | 3.41% |
| Medplus Health Services Ltd | 3.39% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 3.28% |
| AJANTA PHARMA LTD. | 3.12% |
| Gland Pharma Ltd | 3.11% |
| Narayana Hrudayalaya Ltd | 2.84% |
| AUROBINDO PHARMA LTD. | 2.36% |
| Zydus Lifesciences Ltd | 2.30% |
| TORRENT PHARMACEUTICALS LTD. | 1.94% |
| PFIZER LTD. | 1.69% |
| Alkem Laboratories Ltd | 1.69% |
| Thyrocare Technologies Ltd | 1.59% |
| Sanofi India Ltd | 1.51% |
| IPCA LABORATORIES LTD. | 1.39% |
| FORTIS HEALTHCARE LTD. | 1.33% |
| Syngene International Ltd | 0.96% |
| BIOCON LTD. | 0.90% |
| Dr. Lal PathLabs Ltd | 0.87% |
| Orchid Pharma Ltd | 0.62% |
| ASTRAZENECA PHARMA INDIA LTD. | 0.56% |
| INDOCO REMEDIES LTD. | 0.47% |